Sudden unexpected death in epilepsy is prevented by blocking postictal hypoxia.

Area of Science:

• Neuroscience
• Pharmacology
• Epileptology

Background:

• Sudden unexpected death in epilepsy (SUDEP) is the primary cause of mortality in patients with intractable epilepsy.
• The precise mechanisms driving SUDEP, often following tonic-clonic seizures, remain unclear, hindering preventative treatment development.
• Seizures can cause vasoconstriction, leading to brain hypoperfusion and hypoxia, suggesting a potential role in SUDEP when seizures affect the brainstem.

Purpose of the Study:

• To test a neurovascular hypothesis for SUDEP by investigating the efficacy of preventing seizure-induced vasoconstriction.
• To evaluate the potential of cyclooxygenase-2 and L-type calcium channel antagonists in preventing seizure-induced premature mortality.
• To explore the role of spreading depolarization in SUDEP.

Main Methods:

• Utilized awake, non-anesthetized mouse models for both acute and chronic seizure-induced premature mortality.
• Administered cyclooxygenase-2 (ibuprofen) and L-type calcium channel (nicardipine) antagonists to prevent seizure-induced vasoconstriction.
• Assessed the impact of these pharmacological interventions on survival rates and examined spreading depolarization in acute models.

Main Results:

• Both ibuprofen and nicardipine significantly extended survival in mouse models of seizure-induced premature mortality.
• Effective drug levels were maintained systemically, demonstrating the drugs' potential for therapeutic intervention.
• The neurovascular hypothesis, rather than spreading depolarization, was supported as the primary mechanism.

Conclusions:

• These findings provide proof-of-principle for a neurovascular-based mechanism in SUDEP.
• Currently available drugs targeting vasoconstriction show promise as a preventative strategy for SUDEP.
• Further research into neurovascular pathways offers a novel approach to mitigating epilepsy-related mortality.